Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Brodows

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|July 27, 2007
Diabetic gastroparesisRobert J Heine, Robert Brodows
American Journal of Hypertension|December 19, 2009
Effects of exenatide on systolic blood pressure in subjects with type 2 diabetesTed Okerson, Ping Yan, Anthony Stonehouse, et al.
Peptides|July 7, 2009
The effect of exenatide re-exposure on safety and efficacyPeter Faludi, Robert Brodows, Jude Burger, et al.
Diabetes Technology & Therapeutics|May 23, 2009
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargineAnthony L McCall, Daniel J Cox, Robert Brodows, et al.
Health and Quality of Life Outcomes|October 13, 2006
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetesKristina Secnik Boye, Louis S Matza, Alan Oglesby, et al.
Clinical Therapeutics|December 26, 2007
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trialAnthony H Barnett, Jude Burger, Don Johns, et al.
Current Medical Research and Opinion|January 26, 2008
Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysisLeonard C Glass, Yongming Qu, Sheila Lenox, et al.
Diabetes Research and Clinical Practice|November 21, 2008
Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylureaYan Gao, Kun Ho Yoon, Lee-Ming Chuang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|July 27, 2007
Diabetic gastroparesisRobert J Heine, Robert Brodows
American Journal of Hypertension|December 19, 2009
Effects of exenatide on systolic blood pressure in subjects with type 2 diabetesTed Okerson, Ping Yan, Anthony Stonehouse, et al.
Peptides|July 7, 2009
The effect of exenatide re-exposure on safety and efficacyPeter Faludi, Robert Brodows, Jude Burger, et al.
Diabetes Technology & Therapeutics|May 23, 2009
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargineAnthony L McCall, Daniel J Cox, Robert Brodows, et al.
Health and Quality of Life Outcomes|October 13, 2006
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetesKristina Secnik Boye, Louis S Matza, Alan Oglesby, et al.
Clinical Therapeutics|December 26, 2007
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trialAnthony H Barnett, Jude Burger, Don Johns, et al.
Current Medical Research and Opinion|January 26, 2008
Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysisLeonard C Glass, Yongming Qu, Sheila Lenox, et al.
Diabetes Research and Clinical Practice|November 21, 2008
Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylureaYan Gao, Kun Ho Yoon, Lee-Ming Chuang, et al.
Pageof 1